by Suzannah Cavanaugh | Jan 8, 2021
Restaurant workers forfeited safety and security to keep their jobs in 2020. Now, growing numbers are turning to unions as the sole solution to a hazardous industry turned intractable. 1. I Don’t Feel Safe When the pandemic’s first wave breached...
by Suzannah Cavanaugh | Dec 16, 2020
This time last year, Moderna, Inc., was starting to look a lot like Theranos. Moderna had spent the large part of a decade selling investors on the idea of an unprecedented product—a messenger RNA drug. The company, valued at $7.5 billion, made history in December...
by Suzannah Cavanaugh | Nov 11, 2020
Pay no attention to the net losses behind the curtain. Moderna Inc. kicked off its third-quarter earnings call with a cause to celebrate. The biotechnology company announced Thursday it’d reached complete, diverse enrollment in phase three trials of its Covid-19...
by Suzannah Cavanaugh | Oct 30, 2020
In the Covid-19 vaccine race, Moderna, Inc. made headlines last week for the representative diversity of its trial candidates. The company touted 37% enrollment by people of color in late-stage trials, a figure that nearly mirrors the 40% of the population U.S....
by Suzannah Cavanaugh | Oct 25, 2020
Walgreens Boots Alliance, Inc. reported dismal fourth-quarter earnings that managed to exceed low-ball estimates. Shares surged in response to surpassed expectations. Walgreens reported adjusted earnings per share (EPS) of $1.02, down 28.2% from the same period last...
